TScan is a clinical-stage biotechnology company dedicated to creating life-changing T-cell therapies for patients by unleashing the potential of the human immune system.
Our approach is based on the premise that conventional T cells provide the most effective way to fight cancer, and that by genetically reprogramming T cells with highly effective, naturally occurring T cell receptors (TCRs), we can harness the power of the human immune system to deliver life-changing therapies to patients.
We are advancing a robust pipeline of TCR-T therapy candidates derived from our proprietary platform to treat patients with heme malignancies and solid tumors.
Our proprietary platform is designed to discover anti-cancer TCRs from patients with exceptional responses to immunotherapy.
We are committed to bringing new immunotherapies to cancer patients and patients with other serious diseases.
830 Winter St. Waltham, Ma 02451
P 857-399-9500 info@tscan.com
Careers
Interested in joining our team? Explore current openings.
TScan Therapeutics
830 Winter Street Waltham, MA 02451
